p38 mitogen-activated protein kinase: a future target for heart failure therapy?
- PMID: 16875983
- DOI: 10.1016/j.jacc.2006.05.005
p38 mitogen-activated protein kinase: a future target for heart failure therapy?
Comment on
-
Activation of p38 mitogen-activated protein kinase contributes to the early cardiodepressant action of tumor necrosis factor.J Am Coll Cardiol. 2006 Aug 1;48(3):545-55. doi: 10.1016/j.jacc.2006.02.072. Epub 2006 Jul 12. J Am Coll Cardiol. 2006. PMID: 16875982
Similar articles
-
Potential of p38-MAPK inhibitors in the treatment of ischaemic heart disease.Pharmacol Ther. 2007 Nov;116(2):192-206. doi: 10.1016/j.pharmthera.2007.06.013. Epub 2007 Jul 24. Pharmacol Ther. 2007. PMID: 17765316 Review.
-
SCIO-469 Scios Inc.Curr Opin Investig Drugs. 2004 Nov;5(11):1205-12. Curr Opin Investig Drugs. 2004. PMID: 15573872 Review.
-
Inhibitors of unactivated p38 MAP kinase.Bioorg Med Chem Lett. 2006 Dec 1;16(23):6102-6. doi: 10.1016/j.bmcl.2006.08.101. Epub 2006 Sep 12. Bioorg Med Chem Lett. 2006. PMID: 16971122
-
Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production.J Cardiovasc Pharmacol. 2007 Jun;49(6):362-8. doi: 10.1097/FJC.0b013e318046f34a. J Cardiovasc Pharmacol. 2007. PMID: 17577100
-
New therapeutic targets in cardiology: p38 alpha mitogen-activated protein kinase for ischemic heart disease.Circulation. 2012 Jul 17;126(3):357-68. doi: 10.1161/CIRCULATIONAHA.111.071886. Circulation. 2012. PMID: 22801653 Review. No abstract available.
Cited by
-
Neuronostatin, a novel peptide encoded by somatostatin gene, regulates cardiac contractile function and cardiomyocyte survival.J Biol Chem. 2012 Feb 10;287(7):4572-80. doi: 10.1074/jbc.M111.289215. Epub 2011 Dec 14. J Biol Chem. 2012. PMID: 22170057 Free PMC article.
-
Neuroendocrine and cardiac metabolic dysfunction and NLRP3 inflammasome activation in adipose tissue and pancreas following chronic spinal cord injury in the mouse.ASN Neuro. 2013 Sep 4;5(4):243-55. doi: 10.1042/AN20130021. ASN Neuro. 2013. PMID: 23924318 Free PMC article.
-
MMI-0100 inhibits cardiac fibrosis in myocardial infarction by direct actions on cardiomyocytes and fibroblasts via MK2 inhibition.J Mol Cell Cardiol. 2014 Dec;77:86-101. doi: 10.1016/j.yjmcc.2014.09.011. Epub 2014 Oct 1. J Mol Cell Cardiol. 2014. PMID: 25257914 Free PMC article.
-
The case for inhibiting p38 mitogen-activated protein kinase in heart failure.Front Pharmacol. 2015 May 12;6:102. doi: 10.3389/fphar.2015.00102. eCollection 2015. Front Pharmacol. 2015. PMID: 26029107 Free PMC article. Review.
-
Common variants associated with changes in levels of circulating free fatty acids after administration of glucose-insulin-potassium (GIK) therapy in the IMMEDIATE trial.Pharmacogenomics J. 2017 Jan;17(1):76-83. doi: 10.1038/tpj.2015.84. Epub 2015 Dec 8. Pharmacogenomics J. 2017. PMID: 26644202 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical